Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay

Sean Patrick Fitzwater, G. Andrew Sechler, Oswaldo Jave, Jorge Coronel, Alberto Mendoza, Robert H Gilman, Jon S. Friedland, David A J Moore

Research output: Contribution to journalArticle

Abstract

Multidrug-resistant tuberculosis (TB) threatens TB control worldwide. The microscopic observation drug susceptibility (MODS) assay is a low-cost, high-performance TB diagnostic tool for rapid liquid culture and direct isoniazid and rifampicin drug susceptibility testing (DST). The objective of this study was to explore the potential for extending the MODS assay to rapid second-line DST and to identify critical concentrations of candidate drugs for prospective testing. Sputum samples from 94 TB culture-positive patients receiving second-line TB agents were cultured following standardised MODS protocols, with a range of titrations of antimicrobial drugs added. Critical concentrations were determined using a modified Kaplan-Meier survival curve analysis. Candidate critical concentrations were determined for capreomycin (10 μg·mL-1), ciprofloxacin (1.25 μg·mL -1), cycloserine (40 μg·mL-1), ethambutol (10 μg·mL-1), ethionamide (5 μg·mL-1), kanamycin (5 μg·mL-1), para-aminosalicylic acid (10 μg·mL-1) and streptomycin (10 μg·mL -1). No cut-off point was identified for the other second-line drugs or for pyrazinamide. At particular concentrations of some second-line TB drugs this novel Kaplan-Meier analysis clearly differentiated populations that were susceptible or resistant. These candidate critical concentrations should now be tested in a range of epidemiological settings to define the performance of direct, second-line TB DST with MODS, offering potential low-cost second-line TB DST capacity. Copyright

Original languageEnglish (US)
Pages (from-to)1163-1171
Number of pages9
JournalEuropean Respiratory Journal
Volume41
Issue number5
DOIs
StatePublished - May 1 2013
Externally publishedYes

Fingerprint

Tuberculosis
Pharmaceutical Preparations
Kaplan-Meier Estimate
Capreomycin
Ethionamide
Aminosalicylic Acid
Cycloserine
Pyrazinamide
Costs and Cost Analysis
Ethambutol
Multidrug-Resistant Tuberculosis
Kanamycin
Isoniazid
Streptomycin
Rifampin
Survival Analysis
Ciprofloxacin
Sputum

Keywords

  • Diagnostics
  • Extensively drug-resistant tuberculosis
  • Multidrug resistance
  • Second-line drug susceptibility testing
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Fitzwater, S. P., Sechler, G. A., Jave, O., Coronel, J., Mendoza, A., Gilman, R. H., ... Moore, D. A. J. (2013). Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay. European Respiratory Journal, 41(5), 1163-1171. https://doi.org/10.1183/09031936.00059812

Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay. / Fitzwater, Sean Patrick; Sechler, G. Andrew; Jave, Oswaldo; Coronel, Jorge; Mendoza, Alberto; Gilman, Robert H; Friedland, Jon S.; Moore, David A J.

In: European Respiratory Journal, Vol. 41, No. 5, 01.05.2013, p. 1163-1171.

Research output: Contribution to journalArticle

Fitzwater, SP, Sechler, GA, Jave, O, Coronel, J, Mendoza, A, Gilman, RH, Friedland, JS & Moore, DAJ 2013, 'Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay', European Respiratory Journal, vol. 41, no. 5, pp. 1163-1171. https://doi.org/10.1183/09031936.00059812
Fitzwater, Sean Patrick ; Sechler, G. Andrew ; Jave, Oswaldo ; Coronel, Jorge ; Mendoza, Alberto ; Gilman, Robert H ; Friedland, Jon S. ; Moore, David A J. / Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay. In: European Respiratory Journal. 2013 ; Vol. 41, No. 5. pp. 1163-1171.
@article{1776464be84d4e84adc26ab18cb123b7,
title = "Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay",
abstract = "Multidrug-resistant tuberculosis (TB) threatens TB control worldwide. The microscopic observation drug susceptibility (MODS) assay is a low-cost, high-performance TB diagnostic tool for rapid liquid culture and direct isoniazid and rifampicin drug susceptibility testing (DST). The objective of this study was to explore the potential for extending the MODS assay to rapid second-line DST and to identify critical concentrations of candidate drugs for prospective testing. Sputum samples from 94 TB culture-positive patients receiving second-line TB agents were cultured following standardised MODS protocols, with a range of titrations of antimicrobial drugs added. Critical concentrations were determined using a modified Kaplan-Meier survival curve analysis. Candidate critical concentrations were determined for capreomycin (10 μg·mL-1), ciprofloxacin (1.25 μg·mL -1), cycloserine (40 μg·mL-1), ethambutol (10 μg·mL-1), ethionamide (5 μg·mL-1), kanamycin (5 μg·mL-1), para-aminosalicylic acid (10 μg·mL-1) and streptomycin (10 μg·mL -1). No cut-off point was identified for the other second-line drugs or for pyrazinamide. At particular concentrations of some second-line TB drugs this novel Kaplan-Meier analysis clearly differentiated populations that were susceptible or resistant. These candidate critical concentrations should now be tested in a range of epidemiological settings to define the performance of direct, second-line TB DST with MODS, offering potential low-cost second-line TB DST capacity. Copyright",
keywords = "Diagnostics, Extensively drug-resistant tuberculosis, Multidrug resistance, Second-line drug susceptibility testing, Tuberculosis",
author = "Fitzwater, {Sean Patrick} and Sechler, {G. Andrew} and Oswaldo Jave and Jorge Coronel and Alberto Mendoza and Gilman, {Robert H} and Friedland, {Jon S.} and Moore, {David A J}",
year = "2013",
month = "5",
day = "1",
doi = "10.1183/09031936.00059812",
language = "English (US)",
volume = "41",
pages = "1163--1171",
journal = "European Respiratory Journal, Supplement",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "5",

}

TY - JOUR

T1 - Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay

AU - Fitzwater, Sean Patrick

AU - Sechler, G. Andrew

AU - Jave, Oswaldo

AU - Coronel, Jorge

AU - Mendoza, Alberto

AU - Gilman, Robert H

AU - Friedland, Jon S.

AU - Moore, David A J

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Multidrug-resistant tuberculosis (TB) threatens TB control worldwide. The microscopic observation drug susceptibility (MODS) assay is a low-cost, high-performance TB diagnostic tool for rapid liquid culture and direct isoniazid and rifampicin drug susceptibility testing (DST). The objective of this study was to explore the potential for extending the MODS assay to rapid second-line DST and to identify critical concentrations of candidate drugs for prospective testing. Sputum samples from 94 TB culture-positive patients receiving second-line TB agents were cultured following standardised MODS protocols, with a range of titrations of antimicrobial drugs added. Critical concentrations were determined using a modified Kaplan-Meier survival curve analysis. Candidate critical concentrations were determined for capreomycin (10 μg·mL-1), ciprofloxacin (1.25 μg·mL -1), cycloserine (40 μg·mL-1), ethambutol (10 μg·mL-1), ethionamide (5 μg·mL-1), kanamycin (5 μg·mL-1), para-aminosalicylic acid (10 μg·mL-1) and streptomycin (10 μg·mL -1). No cut-off point was identified for the other second-line drugs or for pyrazinamide. At particular concentrations of some second-line TB drugs this novel Kaplan-Meier analysis clearly differentiated populations that were susceptible or resistant. These candidate critical concentrations should now be tested in a range of epidemiological settings to define the performance of direct, second-line TB DST with MODS, offering potential low-cost second-line TB DST capacity. Copyright

AB - Multidrug-resistant tuberculosis (TB) threatens TB control worldwide. The microscopic observation drug susceptibility (MODS) assay is a low-cost, high-performance TB diagnostic tool for rapid liquid culture and direct isoniazid and rifampicin drug susceptibility testing (DST). The objective of this study was to explore the potential for extending the MODS assay to rapid second-line DST and to identify critical concentrations of candidate drugs for prospective testing. Sputum samples from 94 TB culture-positive patients receiving second-line TB agents were cultured following standardised MODS protocols, with a range of titrations of antimicrobial drugs added. Critical concentrations were determined using a modified Kaplan-Meier survival curve analysis. Candidate critical concentrations were determined for capreomycin (10 μg·mL-1), ciprofloxacin (1.25 μg·mL -1), cycloserine (40 μg·mL-1), ethambutol (10 μg·mL-1), ethionamide (5 μg·mL-1), kanamycin (5 μg·mL-1), para-aminosalicylic acid (10 μg·mL-1) and streptomycin (10 μg·mL -1). No cut-off point was identified for the other second-line drugs or for pyrazinamide. At particular concentrations of some second-line TB drugs this novel Kaplan-Meier analysis clearly differentiated populations that were susceptible or resistant. These candidate critical concentrations should now be tested in a range of epidemiological settings to define the performance of direct, second-line TB DST with MODS, offering potential low-cost second-line TB DST capacity. Copyright

KW - Diagnostics

KW - Extensively drug-resistant tuberculosis

KW - Multidrug resistance

KW - Second-line drug susceptibility testing

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84874931336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874931336&partnerID=8YFLogxK

U2 - 10.1183/09031936.00059812

DO - 10.1183/09031936.00059812

M3 - Article

C2 - 22903960

AN - SCOPUS:84874931336

VL - 41

SP - 1163

EP - 1171

JO - European Respiratory Journal, Supplement

JF - European Respiratory Journal, Supplement

SN - 0903-1936

IS - 5

ER -